Emerging Role of Eosinophils in Resolution of Arthritis

• Published in: Frontiers in immunology 2021-10, Vol.12, p.764825-764825
• Main Authors: Qin, Yi, Jin, Hui-Zhi, Li, Yu-Jing, Chen, Zhu
• Format: Article
• Language: English
• Subjects: alternatively activated macrophages; Arthritis, Rheumatoid - immunology; Cytokines - immunology; eosinophil; Eosinophils - immunology; Humans; Immunology; Inflammation - immunology; innate lymphoid cells; resolution; rheumatoid arthritis
• ISSN: 1664-3224; 1664-3224
• DOI: 10.3389/fimmu.2021.764825

Eosinophils are a minor component of circulating granulocytes, which are classically viewed as end-stage effector cells in host defense against helminth infection and promoting allergic responses. However, a growing body of evidence has emerged showing that eosinophils are versatile leukocytes acting as an orchestrator in the resolution of inflammation. Rheumatoid arthritis (RA) is the most common chronic inflammatory disease characterized by persistent synovitis that hardly resolves spontaneously. Noteworthy, a specific population of eosinophils, that is, regulatory eosinophils (rEos), was identified in the synovium of RA patients, especially in disease remission. Mechanistically, the rEos in the synovium display a unique pro-resolving signature that is distinct from their counterpart in the lung. Herein, we summarize the latest understanding of eosinophils and their emerging role in promoting the resolution of arthritis. This knowledge is crucial to the design of new approaches to rebalancing immune homeostasis in RA, considering that current therapies are centered on inhibiting pro-inflammatory cytokines and mediators rather than fostering the resolution of inflammation.